Although we found that TGFBI expression was negatively correlated with CD8+ T cells, another study showed that both high stromal TGFBI expression and intratumoral CD8+ T cells infiltration were associated with poor prognosis and drug resistance in lung cancer patients (Nakazawa et al., 2020). The gene discussed is CD8A; the disease is lung cancer.